Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis
Heart Failure Clinics · 2025
DOI: 10.1016/j.hfc.2025.01.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Heart Failure Clinics, 2025. Verfasst von Anam Waheed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Imaging, Department of Radiology, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies, Tomography, Emission-Computed, Single-Photon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Institutes of Health, Pfizer, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Cardiac single photon emission computed tomography using 99mTc-bone avid tracers allows for an accurate noninvasive diagnosis of transthyretin (ATTR) cardiac amyloidosis, a historically underdiagnosed disease. This imaging is recommended in select populations who demonstrate clinical and imaging features of infiltrative cardiomyopathy. It is imperative to concomitantly assess for light chain (AL) cardiac amyloidosis independent of radionuclide scintigraphy for timely management of AL amyloidosis, a deadly disease requiring urgent therapy. Clinical judgement is also key and in some select scenarios an endomyocardial biopsy may be needed even after a noninvasive evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Imaging, Department of Radiology, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Division of Cardiovascular Imaging, Department of Radiology, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Bri…
Förderung
- National Institutes of Health
- Pfizer
- National Heart, Lung, and Blood Institute
- American Heart Association
Zitieren
APA
Waheed, A., & Dorbala, S. (2025). Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis. Heart Failure Clinics. https://doi.org/10.1016/j.hfc.2025.01.009
Vancouver
Waheed A, Dorbala S. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis. Heart Failure Clinics. 2025. doi:10.1016/j.hfc.2025.01.009
BibTeX
@article{Waheed2025,
author = {Waheed, Anam and Dorbala, Sharmila},
title = {Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis},
journal = {Heart Failure Clinics},
year = {2025},
doi = {10.1016/j.hfc.2025.01.009}
}
EUVIMED